Table 3 In vitro susceptibilities of 49 clinical isolates of Aeromonas spp
Antimicrobial agent | Resistant rate (n) | Breakpoints | |
|---|---|---|---|
S | R | ||
Aztreonam | 8.2 (49) | ≤ 4 | ≥ 16 |
Cefuroxime | 8.2 (49) | ≤ 8 | ≥ 32 |
Ceftriaxone | 8.2 (49) | ≤ 1 | ≥ 4 |
Ceftazidime | 6.1 (49) | ≤ 4 | ≥ 16 |
Cefepime | 0.0 (49) | ≤ 8 | ≥ 32 |
Piperacillin/tazobactam | 32.7 (49) | ≤ 16/4 | ≥ 128 /4 |
Meropenem | 71.4 (49) | ≤ 1 | ≥ 4 |
Imipenem | 70.8 (48) | ≤ 1 | ≥ 4 |
Ciprofloxacin | 4.1 (49) | ≤ 1 | ≥ 4 |
Levofoxacin | 2.1 (48) | ≤ 2 | ≥ 8 |
Gentamicin | 4.1 (49) | ≤ 4 | ≥ 16 |
Amikacin | 0.0 (49) | ≤ 16 | ≥ 64 |
Tegacycline | 0.0 (40) | ≤ 2 | ≥ 8 |
Trimethoprim/Sulfamethoxazole | 22.5 (49) | ≤ 2/38 | ≥ 4/76 |